BG103128A - Аналози на паратироидния хормон за лечение на остеопороза - Google Patents

Аналози на паратироидния хормон за лечение на остеопороза

Info

Publication number
BG103128A
BG103128A BG103128A BG10312899A BG103128A BG 103128 A BG103128 A BG 103128A BG 103128 A BG103128 A BG 103128A BG 10312899 A BG10312899 A BG 10312899A BG 103128 A BG103128 A BG 103128A
Authority
BG
Bulgaria
Prior art keywords
analogues
activity
lys26
paratiroid
osteoporosis
Prior art date
Application number
BG103128A
Other languages
Bulgarian (bg)
English (en)
Inventor
Jean - Rene BARBIER
Paul Morley
Witold Neugebauer
Virginia Ross
James Whitfield
Gordon WILLICK
Original Assignee
National Research Council Of Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/691,647 external-priority patent/US5955425A/en
Application filed by National Research Council Of Canada filed Critical National Research Council Of Canada
Publication of BG103128A publication Critical patent/BG103128A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measurement Of Radiation (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BG103128A 1996-08-02 1999-01-28 Аналози на паратироидния хормон за лечение на остеопороза BG103128A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/691,647 US5955425A (en) 1996-08-02 1996-08-02 Parathyroid hormone analogues for the treatment of osteoporosis
US4056097P 1997-03-14 1997-03-14
PCT/CA1997/000547 WO1998005683A1 (en) 1996-08-02 1997-08-01 Parathyroid hormone analogues for the treatment of osteoporosis

Publications (1)

Publication Number Publication Date
BG103128A true BG103128A (bg) 2000-05-31

Family

ID=26717175

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103128A BG103128A (bg) 1996-08-02 1999-01-28 Аналози на паратироидния хормон за лечение на остеопороза

Country Status (24)

Country Link
EP (1) EP0915911B1 (de)
JP (3) JP4122061B2 (de)
KR (1) KR100500859B1 (de)
CN (1) CN1176947C (de)
AT (1) ATE253078T1 (de)
AU (1) AU723728B2 (de)
BG (1) BG103128A (de)
BR (1) BR9711002B1 (de)
CA (1) CA2261564C (de)
CZ (1) CZ34799A3 (de)
DE (1) DE69725850T2 (de)
DK (1) DK0915911T3 (de)
EE (1) EE9900039A (de)
ES (1) ES2207740T3 (de)
FI (1) FI990126A7 (de)
GE (1) GEP20033095B (de)
IS (1) IS4962A (de)
LV (1) LV12293B (de)
NZ (1) NZ333809A (de)
PT (1) PT915911E (de)
RU (1) RU2203286C2 (de)
SI (1) SI9720057A (de)
SK (1) SK287397B6 (de)
WO (1) WO1998005683A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP9901686A0 (en) * 1997-05-14 1999-12-31 Rhone Poulenc Rorer Pharma Peptide parathyroid hormone analogs.
EP1123401A1 (de) 1998-10-22 2001-08-16 The General Hospital Corporation Bioaktive peptide und peptid-derivate von parathyroidhormon (pth) und parathyroidhormon verwandte peptide (pthrp)
AU1633200A (en) 1998-11-25 2000-06-13 General Hospital Corporation, The Human parathyroid hormone modifications, preparation and use
US7169567B1 (en) 1998-12-31 2007-01-30 The General Hospital Corporation Screening assay utilizing the PTH receptor
EP1221963A4 (de) * 1999-07-28 2006-03-22 Univ Pennsylvania Methoden zur hemmung der osteoclastogenese
US6316410B1 (en) 1999-09-22 2001-11-13 National Research Council Of Canada Parathyroid hormone analogues for the treatment of osteoporosis
AU2002339843B2 (en) 2001-07-23 2007-12-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
CA2453646C (en) * 2001-08-17 2008-09-30 Novartis Ag 5-cnac as oral delivery agent for parathyroid hormone fragments
AU2003207512B2 (en) 2002-01-10 2008-06-12 Osteotrophin Llc Treatment of bone disorders with skeletal anabolic drugs
EP1567178A4 (de) * 2002-11-01 2009-07-15 Amgen Inc Modulatoren von rezeptoren für nebenschilddrüsenhormon- und nebenschildsrüsenhormonbezogene proteine
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
CN100508957C (zh) * 2003-01-21 2009-07-08 尤尼金实验室股份有限公司 肽经口输递的改进
CA2621264A1 (en) * 2005-09-06 2007-11-15 Zelos Therapeutics, Inc. Parathyroid hormone analogues and methods of use
CA2659846A1 (en) * 2006-07-31 2008-02-07 Zelos Therapeutics, Inc. Parathyroid hormone analogues and methods of use
CA2672907C (en) 2006-10-13 2013-08-06 Eli Lilly And Company Pegylated pth as pth receptor modulators and uses thereof
MX346714B (es) 2007-08-01 2017-03-24 The General Hospital Corp * Metodos de analisis y seleccion usando receptores acoplados a proteina g y composiciones relacionadas.
CN103002906B (zh) * 2010-05-13 2017-12-29 总医院有限公司 甲状旁腺激素类似物及其应用
CN105440126B (zh) * 2015-12-31 2019-10-25 南京工业大学 治疗骨质疏松的α-螺旋多肽及其制备方法与应用
US11219697B2 (en) 2017-07-15 2022-01-11 The Regents Of The University Of California Osteoadsorptive fluorogenic substrate of cathepsin k for imaging osteoclast activity and migration
US12404393B2 (en) 2018-09-26 2025-09-02 Borealis Ag Propylene copolymer composition with excellent optical and mechanical properties
CN113549144A (zh) * 2021-06-30 2021-10-26 华南理工大学 一种特立帕肽hPTH(1-34)的生产和纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
US5317010A (en) * 1991-10-10 1994-05-31 Peter K. T. Pang Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
CA2126299C (en) * 1994-06-20 2000-12-12 Gordon E. Willick Parathyroid hormone analogues for the treatment of osteoporosis

Also Published As

Publication number Publication date
DE69725850T2 (de) 2004-08-19
JP4224111B2 (ja) 2009-02-12
EP0915911A1 (de) 1999-05-19
GEP20033095B (en) 2003-10-27
AU723728B2 (en) 2000-09-07
CN1176947C (zh) 2004-11-24
FI990126L (fi) 1999-03-31
LV12293A (lv) 1999-06-20
LV12293B (en) 2000-11-20
KR20000029783A (ko) 2000-05-25
FI990126A0 (fi) 1999-01-22
NZ333809A (en) 2000-07-28
CZ34799A3 (cs) 1999-07-14
FI990126A7 (fi) 1999-03-31
BR9711002A (pt) 2002-01-15
BR9711002B1 (pt) 2011-09-06
KR100500859B1 (ko) 2005-07-14
DK0915911T3 (da) 2004-03-08
CA2261564A1 (en) 1998-02-12
ES2207740T3 (es) 2004-06-01
SI9720057A (sl) 1999-12-31
IS4962A (is) 1999-01-29
RU2203286C2 (ru) 2003-04-27
CN1231676A (zh) 1999-10-13
ATE253078T1 (de) 2003-11-15
WO1998005683A1 (en) 1998-02-12
PT915911E (pt) 2004-03-31
AU3690597A (en) 1998-02-25
JP2009057386A (ja) 2009-03-19
DE69725850D1 (de) 2003-12-04
SK287397B6 (sk) 2010-08-09
JP4122061B2 (ja) 2008-07-23
JP2001500845A (ja) 2001-01-23
CA2261564C (en) 2007-10-30
EP0915911B1 (de) 2003-10-29
EE9900039A (et) 1999-08-16
JP2007254480A (ja) 2007-10-04
SK13299A3 (en) 1999-10-08

Similar Documents

Publication Publication Date Title
BG103128A (bg) Аналози на паратироидния хормон за лечение на остеопороза
MXPA02002977A (es) Analogos de hormona paratiroidea para el tratamiento de la osteoporosis.
HUP0004560A2 (hu) Törést gyógyító PTHrP analógok
DE3585556D1 (de) Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten.
AP9901686A0 (en) Peptide parathyroid hormone analogs.
AU5567790A (en) Device for reinforcing and sustaining the cap of the rotators of a human shoulder joint
AP2000001888A0 (en) Method for treatment of diabetes using peptides analogues of insulin.
EP0293159A3 (de) Parathyroid-Hormon-Antagonisten mit vereinfachter synthetischer Methodologie
SE8405989L (sv) Ledprotes
CA2126299A1 (en) Parathyroid Hormone Analogues for the Treatment of Osteoporosis
ATE377026T1 (de) Behandlung von fettleibigkeit
ITMI912582A1 (it) Mutanti dell'ormone della crescita umano e loro impiego
HUP9904049A3 (en) Growth hormone component and bone anti-resorptive agent in cyclic(coherence)treatment of osteoporosis
Whitfield et al. Comparison of the abilities of human parathyroid hormone (1-31) NH2 and human parathyroid hormone-related protein (1-31) NH2 to stimulate femoral trabecular bone growth in ovariectomized rats
TW360661B (en) Superactive GRF analogs
ATE262538T1 (de) Lhrh-analoga zur behandlung der osteoporose
KR920700224A (ko) 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제